Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

TOF Mass Spectrometer

By Drug Discovery Trends Editor | June 2, 2009

Axima ResonanceShimadzu Scientific Instruments introduces the AXIMA Resonance MALDI QIT TOF mass spectrometer for the structural characterization and sequencing of biomolecules. The combination of quadrupole ion trap (QIT) and high-performance reflectron time-of-flight analyzer provides the highest sensitivity and mass accuracy in Shimadzu’s line of AXIMA MALDI systems. The AXIMA Resonance provides MS/MS and MSn spectra for a wide range of analytes, including pharmaceutical compounds, peptides, glycans, lipids and polymers.


The AXIMA Resonance combines the flexibility and sensitivity of MALDI with the analytical power of an ion trap and the seamless mass accuracy and resolution of time-of-flight. The latest Hypercool technology from Shimadzu Biotech facilitates the use of common MALDI matrices to allow MALDI compatible peptides, glycans, small molecules and others to be easily analyzed in positive or negative ion modes. The power of the ion trap allows the high-resolution selection of parent ions and highly controlled collision induced dissociation (CID) for high sensitivity MSn acquisitions. The incorporation of a TOF analyzer promotes high resolution and high mass accuracy for all ions generated.


The AXIMA Resonance precursor ion selection allows ions from complex mixtures or closely associated neighboring isotopic envelopes to be isolated and fragmented easily. With an isolation resolution of more than 1,000, researchers can analyze samples with similar nominal mass, even those with overlapping isotopic distributions. The AXIMA Resonance utilizes a heavy collision gas, which optimizes the fragmentation of MALDI singly-charged ions, delivering high collisional energy to complex molecular entities.


A variety of software tools comes standard with the AXIMA Resonance, facilitating manual or fully automated operation and seamless analysis of any number of samples. Intuitive software incorporating data-dependent workflows makes it easy for novice and expert users to achieve the maximum result with the minimum user input.


Software suites are available for various AXIMA Resonance operations. Fully enabled for proteomics experiments, Intellimarque provides automated data dependent peptide mass fingerprinting and MS/MS of peptides with optional incorporated Mascot database searching. A tissue imaging suite offers integration with the CHIP™ tissue sample preparation device, automated acquisition of data, and interrogation using proprietary visualization software or automated export to BioMap.


Post translational modification investigation using Shimadzu Biotech’s PTM Finder software permits researchers to use data mining to determine novel or previously undetected peptide modifications. In addition, the AXIMA Resonance can be integrated with LC-MALDI software for experiments and confident identification of offline separated complex mixtures with automated MS/MS.


SeqLab, Shimadzu’s newly released de-novo sequencing software, is optimized for use with the AXIMA Resonance, which can provide very high mass accuracy tandem mass spectrometric data, enhancing the success of de-novo sequencing. SeqLab can make use of related MS/MS/MS data, which provide more information, and complete the sequence across the length of the peptide.


The AXIMA Resonance is compatible with other MALDI mass spectrometers that use microtitre plate target format or an appropriate adaptor. For example, samples may be screened in a high-throughput manner using an AXIMA Confidence or Performance, or other compatible MALDI mass spectrometers. Ions of particular interest, such as a post-translationally modified peptide or glycan, may be investigated further using the AXIMA Resonance.


The compact floor-standing geometry is designed to maximize laboratory space and allow easy installation and servicing. The system is delivered ready to install requiring no assembly on site.


Shimadzu Scientific Instruments www.shimadzu.com/


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE